{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T17:20:33Z","timestamp":1775236833200,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100005565","name":"Janssen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s40744-022-00518-w","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T17:06:51Z","timestamp":1672420011000},"page":"489-505","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic Arthritis"],"prefix":"10.1007","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct05049798","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1802-7311","authenticated-orcid":false,"given":"Stefan","family":"Siebert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ennio","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Sharaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Contr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Theander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n","family":"Queiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Gossec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"issue":"1","key":"518_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semarthrit.2018.01.003","volume":"48","author":"L Scotti","year":"2018","unstructured":"Scotti L, Franchi M, Marchesoni A, Corrao G. Prevalence and incidence of psoriatic arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2018;48(1):28\u201334. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.01.003.","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"518_CR2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376(10):957\u201370. https:\/\/doi.org\/10.1056\/NEJMra1505557.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"518_CR3","doi-asserted-by":"publisher","first-page":"i37","DOI":"10.1093\/rheumatology\/kez383","volume":"59","author":"A Ogdie","year":"2020","unstructured":"Ogdie A, Coates LC, Gladman DD. Treatment guidelines in psoriatic arthritis. Rheumatology (Oxford). 2020;59(Suppl 1):i37\u201346. https:\/\/doi.org\/10.1093\/rheumatology\/kez383.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"518_CR4","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/1744666X.2021.1825941","volume":"16","author":"E Lubrano","year":"2020","unstructured":"Lubrano E, Scriffignano S, Perrotta FM. Multimorbidity and comorbidity in psoriatic arthritis\u2014a perspective. Expert Rev Clin Immunol. 2020;16(10):963\u201372. https:\/\/doi.org\/10.1080\/1744666X.2021.1825941.","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"518_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/art.40726","volume":"71","author":"JA Singh","year":"2019","unstructured":"Singh JA, Guyatt G, Ogdie A, et\u00a0al. Special article: 2018 American college of rheumatology\/national psoriasis foundation guideline for the treatment of psoriatic arthritis. Arthritis Rheumatol. 2019;71(1):5\u201332. https:\/\/doi.org\/10.1002\/art.40726.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"518_CR6","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","volume":"79","author":"L Gossec","year":"2020","unstructured":"Gossec L, Baraliakos X, Kerschbaumer A, et\u00a0al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis. 2020;79(6):700\u201312. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217159.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"518_CR7","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/art.39573","volume":"68","author":"LC Coates","year":"2016","unstructured":"Coates LC, Kavanaugh A, Mease PJ, et\u00a0al. Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol. 2016;68(5):1060\u201371. https:\/\/doi.org\/10.1002\/art.39573.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"518_CR8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrrheum.2016.183","volume":"12","author":"L Gossec","year":"2016","unstructured":"Gossec L, Coates LC, de Wit M, et\u00a0al. Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations. Nat Rev Rheumatol. 2016;12(12):743\u201350. https:\/\/doi.org\/10.1038\/nrrheum.2016.183.","journal-title":"Nat Rev Rheumatol"},{"key":"518_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001083","author":"E Dures","year":"2020","unstructured":"Dures E, Shepperd S, Mukherjee S, et\u00a0al. Treat-to-target in PsA: methods and necessity. RMD Open. 2020. https:\/\/doi.org\/10.1136\/rmdopen-2019-001083.","journal-title":"RMD Open"},{"issue":"10","key":"518_CR10","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/acr.22860","volume":"68","author":"P Vashisht","year":"2016","unstructured":"Vashisht P, Sayles H, Cannella AC, Mikuls TR, Michaud K. Generalizability of patients with rheumatoid arthritis in biologic agent clinical trials. Arthritis Care Res (Hoboken). 2016;68(10):1478\u201388. https:\/\/doi.org\/10.1002\/acr.22860.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"518_CR11","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/bjd.17849","volume":"181","author":"ZZN Yiu","year":"2019","unstructured":"Yiu ZZN, Mason KJ, Barker J, et\u00a0al. A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis. Br J Dermatol. 2019;181(6):1265\u201371. https:\/\/doi.org\/10.1111\/bjd.17849.","journal-title":"Br J Dermatol"},{"issue":"1","key":"518_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1001\/jamadermatol.2020.4202","volume":"157","author":"ZZN Yiu","year":"2021","unstructured":"Yiu ZZN, Mason KJ, Hampton PJ, et\u00a0al. Randomized trial replication using observational data for comparative effectiveness of secukinumab and ustekinumab in psoriasis: a study from the British association of dermatologists biologics and immunomodulators register. JAMA Dermatol. 2021;157(1):66\u201373. https:\/\/doi.org\/10.1001\/jamadermatol.2020.4202.","journal-title":"JAMA Dermatol"},{"issue":"11","key":"518_CR13","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1002\/art.22193","volume":"54","author":"A Zink","year":"2006","unstructured":"Zink A, Strangfeld A, Schneider M, et\u00a0al. Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials. Arthritis Rheum. 2006;54(11):3399\u2013407. https:\/\/doi.org\/10.1002\/art.22193.","journal-title":"Arthritis Rheum"},{"key":"518_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001756","author":"C Houttekiet","year":"2022","unstructured":"Houttekiet C, de Vlam K, Neerinckx B, Lories R. Systematic review of the use of CRP in clinical trials for psoriatic arthritis: a concern for clinical practice? RMD Open. 2022. https:\/\/doi.org\/10.1136\/rmdopen-2021-001756.","journal-title":"RMD Open"},{"issue":"3","key":"518_CR15","doi-asserted-by":"publisher","first-page":"rkab085","DOI":"10.1093\/rap\/rkab085","volume":"5","author":"A Ishchenko","year":"2021","unstructured":"Ishchenko A, Joly J, Neerinckx B, Lories R, de Vlam K. Evolution of patient characteristics in the era of biologic treatment of psoriatic arthritis: 18-year Belgian experience from the Leuven Spondyloarthritis Biologics Cohort (BioSPAR). Rheumatol Adv Pract. 2021;5(3):rkab085. https:\/\/doi.org\/10.1093\/rap\/rkab085.","journal-title":"Rheumatol Adv Pract."},{"issue":"57 Suppl 7","key":"518_CR16","doi-asserted-by":"publisher","first-page":"vii54","DOI":"10.1093\/rheumatology\/key109","volume":"57","author":"S Monti","year":"2018","unstructured":"Monti S, Grosso V, Todoerti M, Caporali R. Randomized controlled trials and real-world data: differences and similarities to untangle literature data. Rheumatology (Oxford). 2018;57(57 Suppl 7):vii54\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/key109.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"518_CR17","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1136\/annrheumdis-2012-203018","volume":"72","author":"KM Fagerli","year":"2013","unstructured":"Fagerli KM, Lie E, van der Heijde D, et\u00a0al. Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study. Ann Rheum Dis. 2013;72(11):1840\u20134. https:\/\/doi.org\/10.1136\/annrheumdis-2012-203018.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"518_CR18","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, et\u00a0al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665\u201373. https:\/\/doi.org\/10.1002\/art.21972.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"518_CR19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/annrheumdis-2016-209511","volume":"76","author":"D Aletaha","year":"2017","unstructured":"Aletaha D, Alasti F, Smolen JS. Disease activity states of the DAPSA, a psoriatic arthritis specific instrument, are valid against functional status and structural progression. Ann Rheum Dis. 2017;76(2):418\u201321. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209511.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"518_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/ard.2008.102053","volume":"69","author":"LC Coates","year":"2010","unstructured":"Coates LC, Fransen J, Helliwell PS. Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis. 2010;69(1):48\u201353. https:\/\/doi.org\/10.1136\/ard.2008.102053.","journal-title":"Ann Rheum Dis"},{"key":"518_CR21","unstructured":"ActiGraph. ActiGraph CentrePoint Insight Watch. 2022. https:\/\/actigraphcorp.com\/cpiw\/. Accessed 7 Nov 2022."},{"issue":"11","key":"518_CR22","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1136\/annrheumdis-2021-220263","volume":"80","author":"JS Smolen","year":"2021","unstructured":"Smolen JS, Siebert S, Korotaeva TV, et\u00a0al. Effectiveness of IL-12\/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results. Ann Rheum Dis. 2021;80(11):1419\u201328. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220263.","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-022-00518-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-022-00518-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-022-00518-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T05:37:19Z","timestamp":1678685839000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-022-00518-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["518"],"URL":"https:\/\/doi.org\/10.1007\/s40744-022-00518-w","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,30]]},"assertion":[{"value":"7 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}